Safety Alert for Absorbent Dressings

According to National Institute of Drugs and Food Surveillance (INVIMA), this safety alert involved a device in Colombia that was produced by Covidien Llc..

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
  • Event Number
  • Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    Colombian data is current through June 2019. All of the data comes from the National Institute of Drugs and Food Surveillance (INVIMA), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Colombia.
  • Extra notes in the data
  • Reason
    The manufacturer states that it has detected the possibility that sterile packaging is compromised, the use of products with this condition may increase the risk of infection, leading to possible adverse events on the patient.


  • Model / Serial
  • Product Description
    Primary dressing for slow drainage wounds such as surgical sites, skin tears or poorly draining wounds. Indicated to cover a wound, give or withstand a moist wound environment, and allow the exchange of gases such as oxygen and water vapor to through the device. Surgical incisions, lacerations, central and peripheral line sites, pressure ulcers, stasis ulcers, arterial ulcers, diabetic ulcers, abrasions and donor areas. Lacerations or eye injuries. Used to absorb fluids and secretions in procedures such as postalaparotomy, tumors, infected wounds, chronic wounds, wounds with high exudate and premature rupture of membranes, among others. Primary dressing in arms and legs, secondary dressing in abdomen.
  • Manufacturer


  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source